Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal : ORIGINAL ARTICLE: Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181–9.ORIGINAL ARTICLE: Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012; 366: 1190–9.

✍ Scribed by Ph. I. Spuls; L. Hooft

• Book ID: 117940094
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 68 KB
• Volume: 167
• Category: Article
• ISSN: 0007-0963
• DOI: 10.1111/bjd.12025